These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21415398)

  • 41. Botulinum toxin A treatment of adult upper and lower limb spasticity.
    Hesse S; Brandi-Hesse B; Bardeleben A; Werner C; Funk M
    Drugs Aging; 2001; 18(4):255-62. PubMed ID: 11341473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin--mechanisms of action and clinical use in spasticity.
    Barnes M
    J Rehabil Med; 2003 May; (41 Suppl):56-9. PubMed ID: 12817658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Robot-assisted training compared with an enhanced upper limb therapy programme and with usual care for upper limb functional limitation after stroke: the RATULS three-group RCT.
    Rodgers H; Bosomworth H; Krebs HI; van Wijck F; Howel D; Wilson N; Finch T; Alvarado N; Ternent L; Fernandez-Garcia C; Aird L; Andole S; Cohen DL; Dawson J; Ford GA; Francis R; Hogg S; Hughes N; Price CI; Turner DL; Vale L; Wilkes S; Shaw L
    Health Technol Assess; 2020 Oct; 24(54):1-232. PubMed ID: 33140719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Post stroke hemiplegia: interest of botulinum toxin injection at the upper limb].
    Rousseaux M; Launay MJ; Kozlowski O
    Ann Readapt Med Phys; 2003 Jul; 46(6):286-95. PubMed ID: 12928131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin type A for upper limb spasticity after stroke.
    Shaw L; Rodgers H
    Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
    J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does botulinum toxin treatment improve upper limb active function?
    Levy J; Molteni F; Cannaviello G; Lansaman T; Roche N; Bensmail D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):234-240. PubMed ID: 29960017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of botulinum toxin type A and type B for spasticity in upper and lower limbs.
    Bell KR; Williams F
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):821-35. PubMed ID: 14580040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
    Bakheit AM; Thilmann AF; Ward AB; Poewe W; Wissel J; Muller J; Benecke R; Collin C; Muller F; Ward CD; Neumann C
    Stroke; 2000 Oct; 31(10):2402-6. PubMed ID: 11022071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum toxin in poststroke spasticity.
    Ozcakir S; Sivrioglu K
    Clin Med Res; 2007 Jun; 5(2):132-8. PubMed ID: 17607049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment with botulinum toxin type B for upper-limb spasticity.
    Brashear A; McAfee AL; Kuhn ER; Ambrosius WT
    Arch Phys Med Rehabil; 2003 Jan; 84(1):103-7. PubMed ID: 12589629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity.
    Kanovský P; Slawek J; Denes Z; Platz T; Sassin I; Comes G; Grafe S
    Clin Neuropharmacol; 2009; 32(5):259-65. PubMed ID: 19644361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum toxin for the management of muscle overactivity and spasticity after stroke.
    Esquenazi A; Mayer N
    Curr Atheroscler Rep; 2001 Jul; 3(4):295-8. PubMed ID: 11389794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of dynamic lycra orthosis as an adjunct to rehabilitation after botulinum toxin-A injection of the upper-limb in adults following stroke: A single-blinded randomized controlled pilot study.
    Giray E; Gencer Atalay K; Eren N; Gündüz OH; Karadag-Saygi E
    Top Stroke Rehabil; 2020 Sep; 27(6):473-481. PubMed ID: 31868130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can the early use of botulinum toxin in post stroke spasticity reduce contracture development? A randomised controlled trial.
    Lindsay C; Ispoglou S; Helliwell B; Hicklin D; Sturman S; Pandyan A
    Clin Rehabil; 2021 Mar; 35(3):399-409. PubMed ID: 33040610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin A in the treatment of spasticity: functional implications and patient selection.
    Pierson SH; Katz DI; Tarsy D
    Arch Phys Med Rehabil; 1996 Jul; 77(7):717-21. PubMed ID: 8670002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review.
    Elia AE; Filippini G; Calandrella D; Albanese A
    Mov Disord; 2009 Apr; 24(6):801-12. PubMed ID: 19224614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Precise quantification of the time course of voluntary activation capacity following Botulinum toxin injections in the biceps brachii muscles of chronic stroke survivors.
    Chandra S; Afsharipour B; Rymer WZ; Suresh NL
    J Neuroeng Rehabil; 2020 Jul; 17(1):102. PubMed ID: 32703213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.